Surgical Replacement and Transcatheter Aortic Valve Implantation Trial 10 Year Follow-up
Recruiting
- Conditions
- severe aortic valve stenosis10046973
- Registration Number
- NL-OMON45149
- Lead Sponsor
- Medtronic B.V.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 160
Inclusion Criteria
All subjects currently enrolled in the randomized cohort of the SURTAVI trial
are eligible to consent to 10 year follow-up.
Exclusion Criteria
None
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary objective of the 10 Year follow-up study is prospectively evaluate<br /><br>all-cause mortality or disabling stroke annually up to 10 years between TAVI<br /><br>(Transcatheter Aortic Valve Implantation) and SAVR (Surgical Aortic Valve<br /><br>Replacement).</p><br>
- Secondary Outcome Measures
Name Time Method